✦ LIBER ✦

Ethics and stopping rules in a phase II clinical trial

✍ Scribed by Andreas Nguyen; Shenghua K. Fan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib therapy in myelofibrosis: a p

✍ Mesa, R A; Verstovsek, S; Rivera, C; Pardanani, A; Hussein, K; Lasho, T; Wu, W; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

Phase II clinical trials with rhizoxin i

✍ Hanauske, A-R; Catimel, G; Aamdal, S; ten Bokkel Huinink, W; Paridaens, R; Pavli 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 603 KB

A phase II clinical trial of echinomycin

✍ William J. Gradishar; Nicholas J. Vogelzang; Lary J. Kilton; Steven J. Leibach; 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 285 KB

Docetaxel (TaxotereTM) in advanced gastr

✍ Sulkes, A; Smyth, J; Sessa, C; Dirix, LY; Vermorken, JB; Kaye, S; Wanders, J; Fr 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 745 KB

Electrochemotherapy, a new antitumor tre

✍ Michel Belehradek; Christian Domenge; Bernard Luboinski; Stéphane Orlowski; Jean 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB

A Parallel Phase I/II Clinical Trial Des

✍ Xuelin Huang; Swati Biswas; Yasuhiro Oki; Jean-Pierre Issa; Donald A. Berry 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB